Elsevier

The Lancet

Volume 339, Issue 8786, 18 January 1992, Pages 135-139
The Lancet

ORIGINAL ARTICLES
Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis

https://doi.org/10.1016/0140-6736(92)90207-JGet rights and content

Abstract

Whether antibiotic prophylaxis can prevent bacterial endocarditis is hotly debated. In an attempt to settle this issue, we have assessed the efficacy of prophylaxis for bacterial endocarditis on native valves in a nationwide, case-control study in the Netherlands. Cases were patients with known cardiac disease in whom endocarditis developed within 180 days of a medical or dental procedure for which prophylaxis was indicated. Of a total of 438 patients with endocarditis diagnosed during 2 years, 48 were eligible for the study. Controls were patients with the same cardiac status in whom endocarditis did not develop within 180 days of a similar procedure; of a total of 889 controls from five hospitals, 200 were eligible. Overall, about 1 in 6 patients in both groups had received prophylaxis. The best estimate of protective efficacy was 49% for first-ever endocarditis occurring within 30 days of a procedure. Endocarditis developed within 30 days of a procedure in only 13% of patients with a previously diagnosed heart lesion which predisposed to the disease. The findings suggest that strict adherence to generally accepted recommendations for prophylaxis might do little to decrease the total number of patients with endocarditis in the community.

References (30)

  • Dt Durak et al.

    Apparent failures of endocarditis prophylaxis. Analysis of 52 cases submitted to a national registry

    JAMA

    (1983)
  • Dw Denning et al.

    Failure of single dose amoxycillin as prophylaxis against endocarditis

    Br Med J

    (1984)
  • Mp Walker

    Infective endocarditis: dental implications, prevention and prophylaxis failure

    Clin Prev Dent

    (1984)
  • Dt Durack

    Prophylaxis of infective endocarditis

  • Cited by (314)

    • Antibiotic Prophylaxis Against Infective Endocarditis Before Invasive Dental Procedures

      2022, Journal of the American College of Cardiology
      Citation Excerpt :

      In addition, there have been 6 case-control or cohort studies,24,28,33,35,37,38 5 of which investigated the association between IDPs and IE24,28,33,37,38 (3 reporting a positive association 28,33,37 even though they were small, underpowered, and performed in populations where AP use could have reduced any association). Three studies assessed AP efficacy24,28,35 and 2 reported a protective effect, despite being small and underpowered.28,35 The largest cohort study demonstrated that AP was associated with a nonsignificant 60% reduction in the incidence of oral streptococcal IE among prosthetic-valve patients 3 months following IDPs (77/million procedures vs 195/million procedures; P = 0.08).24

    • Antibiotic prophylaxis of infective endocarditis in patients with predisposing cardiac conditions: French cardiologists' implementation of current guidelines

      2020, International Journal of Cardiology
      Citation Excerpt :

      The AP prescription strategy is based on the recognition of a PCC that carries a risk of developing IE and a procedure at risk of causing IE bacteremia. Whether AP is a crucial factor for the prevention of IE remains debatable since three case–control studies evidenced an association between dental procedures and streptococcal IE [5–7], whereas three others did not [8–10]. But before any conclusion may be drawn, the primary question, as suggested by several authors, is whether the current guidelines are correctly implemented by the main prescribers of IE AP, i.e., dentists and cardiologists [11,12].

    • Infective endocarditis and orthodontic implications in children: A review of the literature

      2020, American Journal of Orthodontics and Dentofacial Orthopedics
    View all citing articles on Scopus
    View full text